Advertisement
Letter to the Editor| Volume 85, ISSUE 1, P90-122, July 2022

Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England”

  • Borbàla Zsigmond
    Correspondence
    Corresponding author: St. George's Hospital, Department of Paediatric Infectious Diseases, Blackshaw Road, London SW17 0QT, United Kingdom.
    Affiliations
    Department of Paediatric Infectious Diseases, St. George's Hospital, Blackshaw Road, London SW17 0QT, UK

    Immunisation Division, UK Health Security Agency, 61 Colindale Avenue, London, UK
    Search for articles by this author
  • Aodhán Seán Breathnach
    Affiliations
    Department of Infection, St George's University Hospitals NHS Foundation Trust, London, UK

    Immunisation Division, UK Health Security Agency, 61 Colindale Avenue, London, UK
    Search for articles by this author
  • Anna Mensah
    Affiliations
    Institute of Infection and Immunity, St George's University of London, UK

    Immunisation Division, UK Health Security Agency, 61 Colindale Avenue, London, UK
    Search for articles by this author
  • Shamez N Ladhani
    Affiliations
    Department of Paediatric Infectious Diseases, St. George's Hospital, Blackshaw Road, London SW17 0QT, UK

    Department of Infection, St George's University Hospitals NHS Foundation Trust, London, UK

    Institute of Infection and Immunity, St George's University of London, UK

    Immunisation Division, UK Health Security Agency, 61 Colindale Avenue, London, UK
    Search for articles by this author
Published:April 10, 2022DOI:https://doi.org/10.1016/j.jinf.2022.04.020
Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England”
Previous ArticleAssociation of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021
Next ArticleHow China responds to Omicron

      Graphical abstract

      Image, graphical abstract
      Graphical Abstract
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Chappell H.
        • Patel R.
        • Driessens C.
        • et al.
        Immunocompromised children and young people are at no increased risk of severe COVID-19.
        J Infect. 2022; 84: 31-39
        View in Article
        • Castagnoli R.
        • Votto M.
        • Licari A.
        • et al.
        Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review.
        JAMA Pediatr. 2020; 174: 882-889
        View in Article
        • Andrews N.
        • Tessier E.
        • Stowe J.
        • et al.
        Duration of protection against mild and severe disease by Covid-19 vaccines.
        N Engl J Med. 2022; 386: 340-350
        View in Article
        • Gurdasani D.
        • Bhatt S.
        • Costello A.
        • et al.
        Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis.
        J R Soc Med. 2021; 114: 513-524
        View in Article

      5. UK Health Security Agency. Official Statistics: National flu and COVID-19 surveillance reports: 2021 to 2022 season. Available at: https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season (accessed 05 February 2022.

        View in Article
        • Taylor A.
        • Whittaker E.
        The changing epidemiology of respiratory viruses in children during the COVID-19 pandemic: a Canary in a COVID Time.
        Pediatr Infect Dis J. 2022; 41: e46-ee8
        View in Article
        • Ward J.L.
        • Harwood R.
        • Smith C.
        • et al.
        Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.
        Nat Med. 2022; 28: 193-200
        View in Article
        • Powell A.A.
        • et al.
        Adolescent vaccination with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine and effectiveness of the first dose against COVID-19: national test-negative case-control study, England.
        MedRxiv. 2021; https://doi.org/10.1101/2021121021267408
        View in Article
        • Prunas O.
        • Weinberger D.M.
        • Pitzer V.E.
        • et al.
        Waning effectiveness of the BNT162b2 vaccine against infection in adolescents.
        medRxiv. 2022; https://doi.org/10.1101/2022.01.04.22268776
        View in Article
        • Olson S.M.
        • Newhams M.M.
        • Halasa N.B.
        • et al.
        Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents.
        N Engl J Med. 2022; https://doi.org/10.1056/NEJMoa2117995
        View in Article

      Article info

      Publication history

      Published online: April 10, 2022
      Accepted: April 6, 2022

      Identification

      DOI: https://doi.org/10.1016/j.jinf.2022.04.020

      Copyright

      Crown Copyright © 2022 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX